|
Sign In to gain access to subscriptions and/or personal tools.
|
This version was published on September
1, 2006
Journal of Biomolecular Screening, Vol. 11, No. 6,
688-693 (2006)
DOI: 10.1177/1087057106289891
A Rapid Functional Assay for the Human Trace Amine-Associated Receptor 1 Based on the Mobilization of Internal Calcium
Hernán A. Navarro
Center for Organic and Medicinal Chemistry, RTI International, Research Triangle Park, North Carolina
Brian P. Gilmour
Center for Organic and Medicinal Chemistry, RTI International, Research Triangle Park, North Carolina
Anita H. Lewin
Center for Organic and Medicinal Chemistry, RTI International, Research Triangle Park, North Carolina
The molecular targets for trace amines (TAs) such as p-tyramine and ß-phenylethylamine have been recently discovered and have been shown to comprise a family of G-protein-coupled receptors based on DNA sequence homologies. These have been termed trace amine-associated receptors (TAARs) because TAs do not activate all of the identified receptors. Because TA may be involved in modulating a variety of behaviors including mood, cognition, and addiction, it is of interest to discover novel ligands for TAARs to probe the role TAs play in brain function. Pharmacophore development for the Gs-coupled human TAAR1 (hTAAR1) would be aided by a rapid functional assay amenable to screening libraries of compounds. Accordingly, the authors used RD-HGA16 CHO-1 cells from Molecular Devices, which stably express the promiscuous Gq, G 16, to create a cell line stably expressing hTAAR1, thereby coupling receptor activation to the mobilization of internal calcium. They used this cell line to develop a homogenous fluorometric imaging plate reader-based assay using the Calcium 3 fluorescent dye. The EC50 and Emax data obtained for known TAs are in close agreement with previous work using transient hTAAR1 expression systems or a chimeric receptor. These data indicate that the hTAAR1 retains its reported pharmacological characteristics when coupled to G 16.
Key Words: human trace amine calcium mobilization G 16
References
- Premont RT, Gainetdinov RR, Caron MG: Following the trace of elusive amines. Proc Natl Acad Sci U S A 2001;98: 9474-9475.[Free Full Text]
- Branchek TA, Blackburn TP: Trace amine receptors as targets for novel therapeutics: legend, myth and fact. Curr Opin Pharmacol 2003;3: 90-97.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Jones RS: Specific enhancement of neuronal responses to catecholamine by p-tyramine. J Neurosci Res 1981;6: 49-61.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Mercuri NB, Bernardi G: The "magic" of L-dopa: why is it the gold standard Parkinsons disease therapy? Trends Pharmacol Sci 2005;26: 341-344.[CrossRef][Medline]
[Order article via Infotrieve]
- Miller GM, Verrico CD, Jassen A, Konar M, Yang H, Panas H, et al: Primate trace amine receptor 1 modulation by the dopamine transporter. J Pharmacol Exp Ther 2005;313: 983-994.[Abstract/Free Full Text]
- Dourish CT, Cooper SJ: Pharmacology of beta-phenylethylamine-induced seizures in mice. Prog Neuropsychopharmacol Biol Psychiatry 1983;7: 787-790.[CrossRef][Medline]
[Order article via Infotrieve]
- Berretta N, Giustizieri M, Bernardi G, Mercuri NB: Trace amines reduce GABA(B) receptor-mediated presynaptic inhibition at GABAergic synapses of the rat substantia nigra pars compacta. Brain Res 2005;1062: 175-178.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Federici M, Geracitano R, Tozzi A, Longone P, Di Angelantonio S, Bengtson CP, et al: Trace amines depress GABA B response in dopaminergic neurons by inhibiting G-betagamma-gated inwardly rectifying potassium channels. Mol Pharmacol 2005;67: 1283-1290.[Abstract/Free Full Text]
- Boulton AA: Some aspects of basic psychopharmacology: the trace amines. Prog Neuropsychopharmacol Biol Psychiatry 1982;6: 563-570.[CrossRef][Medline]
[Order article via Infotrieve]
- Anderson GM, Gerner RH, Cohen DJ, Fairbanks L: Central tryptamine turnover in depression, schizophrenia, and anorexia: measurement of indoleacetic acid in cerebrospinal fluid. Biol Psychiatry 1984;19: 1427-1435.[ISI][Medline]
[Order article via Infotrieve]
- Duan J, Martinez M, Sanders AR, Hou C, Saitou N, Kitano T, et al: Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromo-some 6q23.2 are associated with susceptibility to schizophrenia. Am J Hum Genet 2004;75: 624-638.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Davis BA, Boulton AA: The trace amines and their acidic metabolites in depressionan overview. Prog Neuropsychopharmacol Biol Psychiatry 1994;18: 17-45.[CrossRef][Medline]
[Order article via Infotrieve]
- Baker GB, Coutts RT, Greenshaw AJ: Neurochemical and metabolic aspects of antidepressants: an overview. J Psychiatry Neurosci 2000; 25: 481-496.[ISI][Medline]
[Order article via Infotrieve]
- Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, et al: Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci U S A 2001;98: 8966-8971.[Abstract/Free Full Text]
- Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, et al: Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neuro-transmitters are agonists of a rat trace amine receptor. Mol Pharmacol 2001;60: 1181-1188.[Abstract/Free Full Text]
- Lindemann L, Ebeling M, Kratochwil NA, Bunzow JR, Grandy DK, Hoener MC: Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. Genomics 2005;85: 372-385.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Lindemann L, Hoener MC: A renaissance in trace amines inspired by a novel GPCR family. Trends Pharmacol Sci 2005;26: 274-281.[CrossRef][Medline]
[Order article via Infotrieve]
- Offermanns S, Simon MI: G alpha 15 and G alpha 16 couple a wide variety of receptors to phospholipase C. J Biol Chem 1995;270: 15175-15180.[Abstract/Free Full Text]
- Yin T, Tu Y, Johnstone EM, Little SP: A characterization of the trace amine receptor 1 [abstract]. Receptor Program No. 961.5. Washington, DC: Society for Neuroscience, 2004.
- Harding WW, Schmidt M, Tidgewell K, Kannan P, Holden KG, Gilmour B, et al: Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin A. J Nat Prod 2006;69: 107-112.[CrossRef][Medline]
[Order article via Infotrieve]

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Z. Xie, S. V. Westmoreland, M. E. Bahn, G.-L. Chen, H. Yang, E. J. Vallender, W.-D. Yao, B. K. Madras, and G. M. Miller
Rhesus Monkey Trace Amine-Associated Receptor 1 Signaling: Enhancement by Monoamine Transporters and Attenuation by the D2 Autoreceptor in Vitro
J. Pharmacol. Exp. Ther.,
April 1, 2007;
321(1):
116 - 127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Wainscott, S. P. Little, T. Yin, Y. Tu, V. P. Rocco, J. X. He, and D. L. Nelson
Pharmacologic Characterization of the Cloned Human Trace Amine-Associated Receptor1 (TAAR1) and Evidence for Species Differences with the Rat TAAR1
J. Pharmacol. Exp. Ther.,
January 1, 2007;
320(1):
475 - 485.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|